|
1
|
Jankowski R, Rumeau C, Gallet P and Nguyen
DT: Nasal polyposis (or chronic olfactory rhinitis). Eur Ann
Otorhinolaryngol Head Neck Dis. 135:191–196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khairuddin NK, Salina H, Gendeh BS, Wan
Hamizan AK and Lund VJ: Quality of life and recurrence of disease
in patients with eosinophilic and non-eosinophilic 1 chronic
rhinosinusitis with nasal polyposis. Med J Malaysia. 73:1–6.
2018.PubMed/NCBI
|
|
3
|
Fokkens WJ, Lund VJ, Mullol J, Bachert C,
Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, et
al: EPOS 2012: European position paper on rhinosinusitis and nasal
polyps 2012. A summary for otorhinolaryngologists. Rhinology.
50:1–12. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stevens WW, Schleimer RP, Chandra RK and
Peters AT: Biology of nasal polyposis. J Allergy Clin Immunol.
133:1503–1503.e1. 4–2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ungureanu A, Zlatian O, Mitroi G, Drocaş
A, Ţîrcă T, Călina D, Dehelean C, Docea AO, Izotov BN, Rakitskii
VN, et al: Staphylococcus aureus colonisation in patients from a
primary regional hospital. Mol Med Rep. 16:8771–8780. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calina D, Rosu L, Rosu AF, Ianosi G,
Ianosi S, Zlatian O, Mitrut R, Docea AO, Rogoveanu O and Mitrut P:
Etiological diagnosis and pharmacotherapeutic management of
parapneumonic pleurisy. Farmacia. 64:946–952. 2016.
|
|
7
|
Călina D, Docea AO, Rosu L, Zlatian O,
Rosu AF, Anghelina F, Rogoveanu O, Arsene AL, Nicolae AC, Drăgoi
CM, et al: Antimicrobial resistance development following surgical
site infections. Mol Med Rep. 15:681–688. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zlatian O, Balasoiu AT, Balasoiu M,
Cristea O, Docea AO, Mitrut R, Spandidos DA, Tsatsakis AM, Bancescu
G and Calina D: Antimicrobial resistance in bacterial pathogens
among hospitalised patients with severe invasive infections. Exp
Ther Med. 16:4499–4510. 2018.PubMed/NCBI
|
|
9
|
Dennis SK, Lam K and Luong A: A Review of
classification schemes for chronic rhinosinusitis with nasal
polyposis endotypes. Laryngoscope Investig Otolaryngol. 1:130–134.
2016. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zaravinos A, Bizakis J, Soufla G,
Sourvinos G and Spandidos DA: Mutations and differential expression
of the ras family genes in human nasal polyposis. Int J Oncol.
31:1051–1059. 2007.PubMed/NCBI
|
|
11
|
Zaravinos A, Bizakis J and Spandidos DA:
RKIP and BRAF aberrations in human nasal polyps and the adjacent
turbinate mucosae. Cancer Lett. 264:288–298. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zaravinos A, Soufla G, Bizakis J and
Spandidos DA: Expression analysis of VEGFA, FGF2, TGFbeta1, EGF and
IGF1 in human nasal polyposis. Oncol Rep. 19:385–391.
2008.PubMed/NCBI
|
|
13
|
Zaravinos A, Bizakis J and Spandidos DA:
Prevalence of human papilloma virus and human herpes virus types
1–7 in human nasal polyposis. J Med Virol. 81:1613–1619. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gitomer SA, Fountain CR, Kingdom TT, Getz
AE, Sillau SH, Katial RK and Ramakrishnan VR: Clinical examination
of tissue eosinophilia in patients with chronic rhinosinusitis and
nasal polyposis. Otolaryngol Head Neck Surg. 155:173–178. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koennecke M, Pries R and Wollenberg B:
Regulatory dysfunctions in nasal polyposis. HNO. 66:290–295.
2018.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ickrath P, Kleinsasser N, Ding X, Ginzkey
C, Beyersdorf N, Kerkau T, Hagen R and Hackenberg S: Impact and
modulations of peripheral and edaphic B cell subpopulations in
chronic rhinosinusitis with nasal polyposis. Clin Exp
Otorhinolaryngol. 11:133–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wongratanacheewin S: Significant role of
cytokines and signaling pathway in rheumatoid arthritis, nasal
polyposis and human airway smooth muscle cells. Asian Pac J Allergy
Immunol. 31:1–2. 2013.PubMed/NCBI
|
|
18
|
Chin D and Harvey RJ: Nasal polyposis: An
inflammatory condition requiring effective anti-inflammatory
treatment. Curr Opin Otolaryngol Head Neck Surg. 21:23–30. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tan BK, Peters AT, Schleimer RP and Hulse
KE: Pathogenic and protective roles of B cells and antibodies in
patients with chronic rhinosinusitis. J Allergy Clin Immunol.
141:1553–1560. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen JB, James LK, Davies AM, Wu YB,
Rimmer J, Lund VJ, Chen JH, McDonnell JM, Chan YC, Hutchins GH, et
al: Antibodies and superantibodies in patients with chronic
rhinosinusitis with nasal polyps. J Allergy Clin Immunol.
139:1195–1204 e1111. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pratt E, Collins AM, Sewell WA and Harvey
RJ: Antigen selection in IgE antibodies from individuals with
chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy.
24:416–421. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gonçalves C, Pinaffi JV, Carvalho JF,
Pinna FR, Constantino GT, Voegels RL, Bueno C, Bonfá E and Viana
VS: Antineutrophil cytoplasmic antibodies in chronic rhinosinusitis
may be a marker of undisclosed vasculitis. Am J Rhinol. 21:691–694.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brewington JJ, Filbrandt ET, LaRosa FJ
III, Moncivaiz JD, Ostmann AJ, Strecker LM and Clancy JP: Brushed
nasal epithelial cells are a surrogate for bronchial epithelial
CFTR studies. JCI Insight. 3:32018. View Article : Google Scholar
|
|
24
|
Bridges MA: Culture of airway epithelial
cells collected by a nasal brushing technique. In Vitro Cell Dev
Biol Anim. 33:82–83. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bradding P, Mediwake R, Feather IH, Madden
J, Church MK, Holgate ST and Howarth PH: TNF alpha is localized to
nasal mucosal mast cells and is released in acute allergic
rhinitis. Clin Exp Allergy. 25:406–415. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boita M, Bucca C, Riva G, Heffler E and
Rolla G: Release of type 2 cytokines by epithelial cells of nasal
polyps. J Immunol Res. 2016:26432972016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jacobi HH, Liang Y, Tingsgaard PK, Larsen
PL, Poulsen LK, Skov PS, Haak-Frendscho M, Niles AL and Johansson
O: Dendritic mast cells in the human nasal mucosa. Lab Invest.
78:1179–1184. 1998.PubMed/NCBI
|
|
28
|
Rheinländer A, Schraven B and Bommhardt U:
CD45 in human physiology and clinical medicine. Immunol Lett.
196:22–32. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Casan JM, Wong J, Northcott MJ and Opat S:
Anti-CD20 monoclonal antibodies: Reviewing a revolution. Hum Vaccin
Immunother. Aug 10–2018.(Epub ahead of print). doi:
10.1080/21645515.2018.1508624. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
No authors listed, . Abstracts of The
International Symposium of Recent Update in Rhinosinusitis and
Nasal Polyposis. Med J Malaysia. 71 (Suppl 2):1–35. 2016.
|
|
31
|
Moro K, Yamada T, Tanabe M, Takeuchi T,
Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H and Koyasu S:
Innate production of T(H)2 cytokines by adipose tissue-associated
c-Kit(+)Sca-1(+) lymphoid cells. Nature. 463:540–544. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Halim TY, Krauss RH, Sun AC and Takei F:
Lung natural helper cells are a critical source of Th2 cell-type
cytokines in protease allergen-induced airway inflammation.
Immunity. 36:451–463. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yasuda K, Muto T, Kawagoe T, Matsumoto M,
Sasaki Y, Matsushita K, Taki Y, Futatsugi-Yumikura S, Tsutsui H,
Ishii KJ, et al: Contribution of IL-33-activated type II innate
lymphoid cells to pulmonary eosinophilia in intestinal
nematode-infected mice. Proc Natl Acad Sci USA. 109:3451–3456.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kang SH, Dalcin PT, Piltcher OB and
Migliavacca RO: Chronic rhinosinusitis and nasal polyposis in
cystic fibrosis: Update on diagnosis and treatment. J Bras Pneumol.
41:65–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bachert C, Zhang L and Gevaert P: Current
and future treatment options for adult chronic rhinosinusitis:
Focus on nasal polyposis. J Allergy Clin Immunol. 136:1431–1440.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Csomor P, Sziklai I and Karosi T: Effects
of intranasal steroid treatment on the presence of biofilms in
non-allergic patients with chronic rhinosinusitis with nasal
polyposis. Eur Arch Otorhinolaryngol. 271:1057–1065. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mitroi M, Căpitănescu A, Georgescu CV,
Mogoantă CA, Popescu C, Georgescu M, Mitroi G and Ioniţă E:
Expression pattern of CK7 and CK20 in nasal polyps, at patients
with chronic rhinosinusitis with nasal polyposis. Rom J Morphol
Embryol. 52 (Suppl 3):1051–1057. 2011.PubMed/NCBI
|
|
38
|
van Diest PJ, van Dam P, Henzen-Logmans
SC, Berns E, van der Burg ME, Green J and Vergote I; European
Organization for Research and Treatment of Cancer-Gynaecological
Cancer Cooperative Group, : A scoring system for
immunohistochemical staining: Consensus report of the task force
for basic research of the EORTC-GCCG. J Clin Pathol. 50:801–804.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Davidsson A and Hellquist HB: The
so-called ‘allergic’ nasal polyp. ORL J Otorhinolaryngol Relat
Spec. 55:30–35. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aboud SK, Husain S and Gendeh BS:
Evaluation on quality of life in patients with nasal polyposis
managed with optimal medical therapy. Allergy Rhinol (Providence).
5:2–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cortesina G, Cardarelli L, Riontino E,
Majore L, Ragona R and Bussi M: Multi-center study of recurrent
nasal sinus polyposis: Prognostic factors and possibility of
prophylaxis. Acta Otorhinolaryngol Ital. 19:315–324. 1999.(In
Italian). PubMed/NCBI
|
|
42
|
Settipane GA: Epidemiology of nasal
polyps. Allergy Asthma Proc. 17:231–236. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vento SI, Wolff CH, Salven PJ, Hytönen ML,
Ertama LO and Malmberg CH: Vascular permeability factor/vascular
endothelial growth factor in nasal polyps. Acta Otolaryngol Suppl.
543:170–174. 2000.PubMed/NCBI
|
|
44
|
Diamantopoulos II, Jones NS and Lowe J:
All nasal polyps need histological examination: An audit-based
appraisal of clinical practice. J Laryngol Otol. 114:755–759. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lacroix JS, Zheng CG, Goytom SH, Landis B,
Szalay-Quinodoz I and Malis DD: Histological comparison of nasal
polyposis in black African, Chinese and Caucasian patients.
Rhinology. 40:118–121. 2002.PubMed/NCBI
|
|
46
|
Lathi A, Syed MM, Kalakoti P, Qutub D and
Kishve SP: Clinico-pathological profile of sinonasal masses: A
study from a tertiary care hospital of India. Acta Otorhinolaryngol
Ital. 31:372–377. 2011.PubMed/NCBI
|
|
47
|
Tripathi P and Ranjan R: A comparative
study of histopathology of different types of nasal polyps:
Allergic, inflammatory and neoplastic. Ann Int Med Dent Res.
3:41–45. 2017.
|
|
48
|
Takeda K, Sakakibara S, Yamashita K,
Motooka D, Nakamura S, El Hussien MA, Katayama J, Maeda Y, Nakata
M, Hamada S, et al: Allergic conversion of protective mucosal
immunity against nasal bacteria in patients with chronic
rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. Jul
25–2018.(Epub ahead of print). doi: 10.1016/j.jaci.2018.07.006.
|
|
49
|
Wang X, Guo J, Zhang H, Tao G, Han D, Zhu
X, Fan E and Li Y: Roles of CD43, CD20 and local IgE in the
pathogenesis of nasal polyps. Zhonghua Er Bi Yan Hou Ke Za Zhi.
36:333–334. 2001.(In Chinese). PubMed/NCBI
|
|
50
|
Wu X, Wang LF and Zang YH: Expression of
CD68 CD45RO CD20 and proliferating cell nuclear antigen in nasal
polyps. Zhonghua Er Bi Yan Hou Ke Za Zhi. 38:187–190. 2003.(In
Chinese). PubMed/NCBI
|
|
51
|
Sobol SE, Christodoulopoulos P, Manoukian
JJ, Hauber HP, Frenkiel S, Desrosiers M, Fukakusa M, Schloss MD and
Hamid Q: Cytokine profile of chronic sinusitis in patients with
cystic fibrosis. Arch Otolaryngol Head Neck Surg. 128:1295–1298.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hulse KE, Norton JE, Suh L, Zhong Q,
Mahdavinia M, Simon P, Kern RC, Conley DB, Chandra RK, Tan BK, et
al: Chronic rhinosinusitis with nasal polyps is characterized by
B-cell inflammation and EBV-induced protein 2 expression. J Allergy
Clin Immunol. 131:1075–83, 1083.e1-7. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Min JY, Hulse KE and Tan BK: B-cells and
antibody-mediated pathogenesis in chronic rhinosinusitis with nasal
polyps. Adv Otorhinolaryngol. 79:48–57. 2016.PubMed/NCBI
|
|
54
|
Yoon YH, Jin J, Kwon KR, Kim SH, Rha KS
and Kim YM: The role of B cell Activating Factor (BAFF) expression
on pathogenesis of nasal polyp in chronic rhinosinusitis with nasal
polyposis. Rhinology. 52:390–396. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hulse KE: Immune mechanisms of chronic
rhinosinusitis. Curr Allergy Asthma Rep. 16:12016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen D, Chen L and Xiao L: The progress
study of tumor suppressor gene and apoptosis gene in nasal polyps.
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 29:2099–2102.
2015.(In Chinese). PubMed/NCBI
|
|
57
|
Kowalski ML, Grzegorczyk J, Pawliczak R,
Kornatowski T, Wagrowska-Danilewicz M and Danilewicz M: Decreased
apoptosis and distinct profile of infiltrating cells in the nasal
polyps of patients with aspirin hypersensitivity. Allergy.
57:493–500. 2002. View Article : Google Scholar : PubMed/NCBI
|
